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ABSTRACT
Our previously presented method for high throughput computational screening of
mutant activity (Hediger et al., 2012) is benchmarked against experimentally mea-
sured amidase activity for 22 mutants of Candida antarctica lipase B (CalB). Using an
appropriate cutoff criterion for the computed barriers, the qualitative activity of 15
out of 22 mutants is correctly predicted. The method identifies four of the six most
active mutants with≥3-fold wild type activity and seven out of the eight least active
mutants with ≤0.5-fold wild type activity. The method is further used to screen
all sterically possible (386) double-, triple- and quadruple-mutants constructed
from the most active single mutants. Based on the benchmark test at least 20 new
promising mutants are identified.
Subjects Biochemistry, Biotechnology, Computational Biology
Keywords Enzyme Engineering, Computational Chemistry
INTRODUCTION
In industry, one frequently tries to modify an enzyme in order to enhance its functionality
in a certain way (Patkar et al., 1997; Kolkenbrock et al., 2006; Nakagawa et al., 2007; Naik et
al., 2010; Takwa et al., 2011). From an application point of view, one of the most interesting
questions is how to modify an enzyme such that its activity is enhanced compared to wild
type or such that a new kind of activity is introduced into the enzyme (Ja¨ckel, Kast &
Hilvert, 2008; Frushicheva & Warshel, 2012). It can therefore be of considerable relevance to
have a method available which efficiently allows a priori discrimination between promising
candidates for experimental study and mutants which can be excluded from the study.
Numerous methods are currently being proposed and developed for the description of
enzyme activities, the theoretical background of which ranges from phenomenological
and bioinformatics based approaches (Chica, Doucet & Pelletier, 2005; Zanghellini et
al., 2006; Zhou & Caflisch, 2010; Privett et al., 2012; Suplatov et al., 2012) to quantum
mechanics based ab initio descriptions (Ishida & Kato, 2004; Noodleman et al., 2004;
Friesner & Guallar, 2005; Rod & Ryde, 2005; Claeyssens et al., 2006; Hermann et al., 2009;
Tian & Friesner, 2009; Parks et al., 2009; Altarsha et al., 2010). However one can expect that
methods which are highly demanding in terms of set-up efforts and computational time
are less likely to be employed in industrial contexts where qualitative or semi-quantitative
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Figure 1 Reaction scheme for the formation of TI. Nucleophilic attack by Oγ of S105 on carbonyl
carbon C20 of substrate. R1:−CH2–Cl,R2: −CH2–C5H6.
conclusions can be of sufficient use in the beginning and planning phase of a wet-lab study.
Few approaches, while taking into account a number of approximations and limitations in
accuracy, aim at being used in parallel or prior to experimental work (Himo, 2006; Hu et al.,
2009) and are not designed to be used for high throughput fashion.
Hediger et al. have recently published a computational method for high throughput
computational screening of mutant activity (Hediger et al., 2012) and in this paper we
benchmark the method against experimentally measured amidase activity for mutants of
Candida antarctica lipase B (CalB) and apply the method to identify additional promising
mutants.
METHODS
We introduce the experimental set-up and the methodology for comparing experimental
and computational data. We describe a benchmarking and a combinatorial study of CalB
mutant activity.
Experimentally, variants of Candida Antarctica lipase B (CalB) were either produced in
Pichia pastoris with C-terminal His6-tag for subsequent affinity purification or expressed
in Aspergillus oryzae without terminal tag followed by a three-step purification procedure.
It is generally accepted that in serine protease like enzymes, the formation of the
tetrahedral intermediate (TI, Fig. 1) is rate determining (Ishida & Kato, 2003; Hedstrom,
2002; Fersht, 1985; Polga´r, 1989) and throughout this work we assume that a lower barrier
for this reaction correlates to increased overall activity of the enzyme.
The substrate used throughout this study is N-benzyl-2-chloroacetamide. The
organisms used for expression of the individual variants are indicated in Table 1.
Generation of CalB variants without His-tags
Variants of CalB carrying the CalB signal peptide were generated at the DNA level using
QuickChange mutagenesis on the corresponding gene residing in a dual E. coli/Aspergillus
Pichia pastoris expression vector. The PCR was performed with proofreading DNA
polymerase (New England Biolabs, NEB). To remove parent templates, they were
methylated in vitro prior to PCR with CpG methyltransferase (from NEB) and digested
in vivo after transformation of competent E. coli DH5 α cells (TaKaRa) according to the
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Table 1 Experimental overall activities and calculated reaction barriers of Set S. Activity factors +1/−1 indicate increased/decreased overall
activity. Ao and Pp indicating expression in organisms (Org.) Aspergillus oryzae or Pichia pastoris, respectively. The cutoff to distinguish higher
and lower activity mutants is defined as 12.5 kcal/mol, see text.
Species Experimental Calculated Org.
Activity
[*WT]
Activity-
Factor
Barriers
[kcal/mol]
Activity-
Factor
G39A-T103G-W104F-L278A 11.2 1 13.9 −1 Ao
G39A-L278A 7.0 1 11.3 1 Pp
G39A-W104F 4.2 1 10.6 1 Ao
G39A-T103G-L278A 3.8 1 7.3 1 Ao
G39A-W104F-L278A 3.6 1 11.8 1 Pp
T103G 3.0 1 13.6 −1 Ao
G39A-W104F-I189Y-L278A 2.9 1 10.9 1 Pp
G39A 2.8 1 11.2 1 Ao
L278A 2.5 1 12.8 −1 Ao
W104F 2.0 1 12.0 1 Ao
G39A-T103G-W104Q-L278A 1.9 1 12.8 −1 Ao
G39A-T103G-W104F-D223G-L278A 1.5 1 11.3 1 Pp
G39A-T103G 0.8 −1 7.5 1 Ao
G39A-T42A-T103G-W104F-L278A 0.7 −1 10.4 1 Pp
I189H 0.5 −1 12.9 −1 Pp
G39A-I189G-L278A 0.4 −1 10.7 1 Pp
G41S 0.3 −1 13.4 −1 Pp
I189G 0.2 −1 18.9 −1 Pp
G39A-T103G-W104F-I189H-D223G-L278A 0.1 −1 13.7 −1 Pp
G39A-T103G-W104F-I189H-L278A-A282G-I285A-V286A 0.1 −1 12.9 −1 Pp
A132N 0.0 −1 12.5 −1 Pp
P38H 0.0 −1 12.5 −1 Pp
WT 1.0 – 7.5 –
instructions from the manufacturer. Plasmid DNA was isolated from transformed E. coli
strains, and sequenced to verify the presence of the desired substitutions. Confirmed
plasmid variants were used to transform an Aspergillus oryzae strain that is negative
in pyrG (orotidine-5′-phosphate decarboxylase), proteases pepC (a serine protease
homologous to yscB), alp (an alkaline protease), NpI (a neutral metalloprotease I) to
avoid degradation of the lipase variants during and after fermentation.
The transformed Aspergillus strains were fermented as submerged culture in shake flasks
and the lipase variants secreted into the fermentation medium. After the fermentation,
the lipase variants were purified from the sterile filtered fermentation medium in a 3 step
procedure with (1) hydrophobic interaction chromatography on decylamine-agarose,
(2) buffer exchange by gel filtration and (3) ion exchange chromatography with cation
exchange on SP-sepharose at pH 4.5. The lipase variant solutions were stored frozen.
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Generation of CalB variants with His-tags
Variants of CalB carrying the CalB signal peptide and C-terminal His-tags were generated
at the DNA level using SOE-PCR and inserted into a dual E. coli/Pichia pastoris expression
vector using In-fusion cloning (ClonTech). The SOE-PCR was performed with Phusion
DNA polymerase (NEB) and template DNA of the CalB gene. The cloned plasmids were
transformed in competent E. coli DH5 α cells (TaKaRa). Plasmid DNA was isolated
from transformed E. coli strains, and sequenced to verify the presence of the desired
substitutions. Confirmed plasmid variants were used to transform a Pichia pastoris
strain that is Mut(s), Suc(+), His(−). The transformed Pichia strains were fermented
as submerged culture in deep well plates and secretion of the lipase variants into the
fermentation medium was induced by the addition of methanol. After the fermentation,
the lipase variants were purified from the cleared supernatants using a standard His-tag
purification protocol (Qiagen) and buffer-exhanged into 50 mM phosphate buffer, pH 7.0,
using Amicon Ultra centrifugal filter devices with a 10 kDa cutoff (Merck Millipore).
Activity measurement
Amidase activity of CalB variants was determined in a two-step fluorimetric assay
previously described by Henke & Bornscheuer (2003). First, enzymatic hydrolysis of
N-benzyl-2-chloroacetamide was performed in 96-well microtiter plates in 200 µL
phosphate-buffered aqueous solution pH 7.0 including 10% organic co-solvent (THF
or DMSO). Reactions containing 5 mM amide substrate, 0.3–3 µM enzyme, and 12 µg/mL
BSA were incubated for 18–20 h at 37◦C in a shaker incubator. In a second step, 50 µL
of a 20 mM 4-nitro-7-chloro-benzo-2-oxa-1,3-diazole (NBD-Cl) solution in 1-hexanol
was added and the reaction of NBD-Cl with benzylamine formed during amide hydrolysis
proceeded under identical reaction conditions for another hour.
Fluorescence of the final reaction product was determined with excitation at 485 nm and
measured emission at 538 nm. Calibration of the amide hydrolysis reaction was performed
on each assay plate with benzylamine covering a concentration range between 0.05 and
5 mM. All enzymatic activities were corrected for non-enzymatic background reaction
determined under identical conditions without enzymes present.
Computational details
The computational method used to estimate the reaction barriers of the CalB mutants has
been described in detail earlier (Hediger et al., 2012) and is only summarized here.
As described previously (Hediger et al., 2012), in order to make the method computa-
tionally feasible, relatively approximate treatments of the wave function, structural model,
dynamics and reaction path are used. Given this and the automated setup of calculations,
some inaccurate results will be unavoidable. However, the intent of the method is similar
to experimental high throughput screens of enzyme activity where, for example, negative
results may result from issues unrelated to the intrinsic activity of the enzyme such as
imperfections in the activity assay, low expression yield, protein aggregation, etc. Just like
its experimental counterpart our technique is intended to identify potentially interesting
mutants for further study.
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The reaction barriers are estimated computationally by preparing molecular model
structures (Hediger et al., 2012) (consisting of around 840 atoms) of the enzyme
substrate complex (ES) and the tetrahedral intermediate (TI) in between which linear
interpolation is carried out to generate structures of the enzyme on the reaction path. Such
adiabatic mapping is the most common way to estimate barriers in QM/MM studies of
enzymatic reaction mechanisms. The resulting barriers tend to be in good agreement with
experiment, which indicates that this is a reasonable approximation (see for example Gao
& Truhlar (2002) and Friesner & Guallar (2005)). The geometry of each interpolation
frame is optimized while keeping the distance between the nucleophilic carbon C20 of the
substrate and Oγ of serine 105 (Fig. 1) fixed at a specific value di = dini− i(dini− dfin)/10,
where dini and dfin are the distances between C20 and Oγ in the ES complex and TI,
respectively (in A˚, 10 being the number of interpolation frames and i the interpolation
frame index). In geometry optimization calculations, the gradient convergence criteria is
set to 0.5 kcal/(molA˚) and a linear scaling implementation of the PM6 method (MOZYME;
Stewart, 1996) together with a NDDO cutoff of 15 A˚ is applied. The energy profile of the
reaction barrier at the PM6 level of theory (Stewart, 2007) is subsequently mapped out
by carrying out conventional SCF calculations of each optimized interpolation frame. All
calculations are carried out using the MOPAC suite of programs (Stewart, 1990; Stewart,
2009). The molecular models are based on the crystal structure of the CalB enzyme with
PDB identifier 1LBS (Uppenberg et al., 1995). In order to prevent significant rearrangement
of hydrogen bonding network of surface residues during the optimization, a number
of additional structural constraints are applied in the geometry optimizations, i.e., the
residues S50, P133, Q156, L277 and P280 are kept fixed. These (surface) residues are
observed to rearrange and form new hydrogen bonds in optimizations when no constraints
are applied. Omitting the constraints leads to unconclusive barrier shapes containing many
irregular minima along the reaction coordinate which do not permit to readily define a
reaction barrier.
For the analysis, the reaction barrier is defined by the difference between the highest
energy point on the reaction profile and the energy corresponding to the enzyme substrate
complex. From our calculations (PM6/MOZYME in vacuum), we estimate the wild type
(WT) barrier to be 7.5 kcal/mol.
Experimentally, specific activity of hydrolysis is determined. Given first order kinetics,
saturation of the enzyme with substrate (usual for industrial application) and fast binding
and product release, the catalytic rate constant kcat is directly proportional to the specific
activity under the assumption that the amount of active enzyme remains constant.
This therefore allows the catalytic rate constant kcat and, hence, the barrier height to be
compared to the improvement factors reported in the results section. The approximations
used here in relating the barrier height on the potential energy surface to kcat have been
discussed previously (Hediger et al., 2012).
It is noted that using one CPU per interpolation frame on the reaction barrier, the
complete barrier of one mutant can be computed with 10 CPUs usually within less than
12 h of wall clock time (for a molecular model of the size used in this study). Given a set of
Hediger et al. (2013), PeerJ, DOI 10.7717/peerj.145 5/15
Table 2 Point mutations. The term active site refers to residues with potential direct Van der Waals
contact to the substrate. The term first shell/second shell refers to residues which are adjacent to an active
site/first shell residue.
Target Mutations Type Description
P38 H Second shell (H neutral)
G39 A First shell
G41 S First shell
T42 A Second shell
T103 G First shell
W104 F, Q, Y Active site
A132 N First shell
A141 N, Q Active site
I189 A, G, H, N, Y Active site (G including additional water,
H neutral)
D223 G First shell (Increase of charge by+1)
L278 A Active site
A282 G Active site
I285 A Active site
V286 A First shell
molecular models of the enzyme, and 100 available CPUs, it is possible to screen around
1000 mutants within one week.
Combination mutants
The molecular model of the enzyme and the positions of the point mutations in the
enzyme are illustrated in Fig. 2. The point mutations are listed in Table 2. Two sets of
mutants are introduced in this section: a benchmarking set S and a combinatorial set L, the
definitions of which are provided in the following.
The point mutations are selected based on different design principles. These are either
introduction of structural rearrangements in the active site to change the binding site
properties of the active site (residues P38, G39, G41, T42, T103) (Patkar et al., 1997),
introduction of space to accommodate the substrate (W104, L278, A282, I285, V286),
introduction of dipolar interactions between the enzyme and the substrate (A132, A141,
I189) (Syre´n et al., 2012) or reduction of polarity in the active site (D223). Of course
different heuristic considerations will apply for other enzymes when selecting the single
mutations for combinatorial study. The mutants of the benchmarking study are collected
in a small set S (22 mutants, Table 1). For the combinatorial study, out of the above we
select six residues (G39, T103, W104, A141, I189, L278) which, it is assumed, contribute
strongest to increased activity and define the mutations at each position as listed in Table 3.
Given the position i and the number of mutations at each position gi, in general the upper
limit for the number of mutants M in a combinatorial study can be calculated by writing a
sum term for each type (i.e., “order”) of combination mutant, i.e., single, double, . . . , such
Hediger et al. (2013), PeerJ, DOI 10.7717/peerj.145 6/15
Figure 2 Position of point mutations. (A) Overlay of mutations W104[F, Q, Y]. (B) Overlay of muta-
tions A141[N, Q]. (C) Overlay of mutations of I189[A, G, H, N, Y]. (D) Mutations P38H, G39A, G41S,
T42A, T103G, A132N, L278A, A282G, I285A, V286A. Substrate shown in magenta.
that
M =
∑
i
gi︸ ︷︷ ︸
Single
(o=1)
+
∑
i,j
j>i
gi · gj
︸ ︷︷ ︸
Double
(o=2)
+
∑
i,j,k
k>j>i
gi · gj · gk
︸ ︷︷ ︸
Triple
(o=3)
+ ··· (1)
where each sum term consists of
(
N
o
)
individual terms (N and o being the number of
positions which can be mutated and the order of the mutant, respectively). By this scheme,
considering the mutations listed in Table 3, hypothetically 424 (= 13+ 64+ 154+ 193)
single to four-fold mutants can be constructed. This number is reduced by applying the
restriction that out of the 424 hypothetically possible mutants, 0 single, 2 double, 12 triple
and 24 four-fold combination mutants including the pair A141N/Q-I189Y are discarded
because in the molecular modeling, these side chains could not be allocated spatially in
the same mutant. We further note that 15 out of these remaining 386 mutants (Table 3)
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Table 3 Side chains used for generation of combinatorial set L. i and gi indicate the position in the back
bone and the number of mutations at that position, respectively.
Mutation i gi
G39A 39 1
T103G 103 1
W104{F, Q, Y} 104 3
A141{N, Q} 141 2
I189{A, G, H, N, Y} 189 5
L278A 278 1
Table 4 Combinatorial study details. From the possible mutants, the combinations containing the pair
A141N/Q-I189Y, the mutants with inconclusive barriers and the mutants with barriers >19.0 kcal/mol
are subtracted to give the number of mutants in set L. “Only Set L” indicates the number of mutants
uniquely present in set L and not in set S.
Order Possible Containing
A141N/Q-I189Y
Inconclusive
barrier
Barrier > 19.0
[kcal/mol]
Set L Only
Set L
Single 13 0 0 0 13 7
Double 64 2 4 8 50 47
Triple 154 12 21 20 101 98
Four-fold 193 24 36 19 114 111
Total 424 38 61 47 278 263
are present also in the benchmarking set S and thus the combinatorial study consists of
371 unique mutants. A detailed documentation of the number of screened residues in the
combinatorial study is provided in Table 4.
Prior to analysis, the reaction barriers of the combination mutants are inspected visually
and mutants with irregularly shaped barriers, i.e., consisting of multiple peaks of similar
height along the reaction coordinate, are discarded. This step is done simply because the
calculations yield inconclusive results, so the most conservative choice is to consider it
a non-promising candidate for a more active variant. Generating plots of the profiles is
completely automated and visual inspection can easily be done for hundreds of mutants.
Furthermore, out of the mutants with regular reaction barrier shapes, we discard those
mutants with barriers >19.0 kcal/mol (i.e., the largest calculated barrier from set S).
Following these selection criteria, 61 mutants are discarded because of inconclusive barrier
shapes and 47 mutants because the barrier is higher than 19 kcal/mol (a distribution of
reaction barriers is shown in Fig. S1). After these filtering steps, 278 mutants remain in the
combinatorial study which we collect in the large set L (out of which 15 are in set S). An
overview on the distribution of reaction barriers for the mutants from set L is provided
Fig. S2 of the supporting information.
We note that in set S, all barriers appear regular in shape and no mutant contains the
A141N/Q and I189Y pair.
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Figure 3 Comparison of experimental and computed activities. 1/−1 correspond to increased/
decreased overall activity, respectively. Prediction rate is 15/22(68%).
Figure 4 Barrier scatter plot of set S. 22 mutants; the cutoff value cS is discussed in the text.
RESULTS AND DISCUSSION
Set S: Calibration of the accuracy
The correspondence of the computed barriers from set S with the experimental assay is
shown in Fig. 3. The exact data is reported in Table 1. A scatterplot of calculated reaction
barriers is presented in Fig. 4.
We note that in set S, the highest experimentally observed activity is around 11 times
the wild type activity (G39A-T103G-W104F-L278A, Table 1), while roughly ten mutants
show no increased activity. In total, six mutants show 3-fold or higher wild type activity.
In the calculations, only one mutant is observed to have a lower barrier than the wild type
(7.3 kcal/mol, G39A-T103G-L278A) and the highest observed barrier is 18.9 kcal/mol
(I189G).
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Given the approximations introduced to make the method sufficiently efficient, it is
noted that the intent of the method is not a quantitative ranking of the reaction barriers,
but to identify promising mutants for, and to eliminate non-promising mutants from,
experimental consideration. Therefore only qualitative changes in overall activity are
considered, which are represented by the activity factors (+1/−1).
We categorize the experimentally observed activities and the predicted reaction barriers
as follows. From experiment, a mutant with activity of 1.2 (0.8) times the wild type activity
or higher (lower) is considered as improving (degrading). Correspondingly, the computed
difference in reaction barrier height between a mutant and the wild type is expressed
in qualitative terms. For the comparison with the experimental activity assay, we define
a barrier cutoff cS = 12.5 kcal/mol to distinguish between potentially improving and
degrading mutants in set S. The value of 12.5 kcal/mol is chosen such as to maximize
the agreement with experiment, which is 68%, i.e., using a smaller or larger value for the
cutoff will decrease this value.
A mutant with a predicted barrier ≥ cS (12.5 kcal/mol) is considered to likely have
decreased activity compared to the wild type while mutants with reaction barriers< cS are
considered likely having increased activity.
We note that defining the cutoff is done purely for a post hoc comparison of exper-
imental and computed data. When using the computed barriers to identify promising
experimental mutants, one simply chooses the N mutants with the lowest barriers, where
N is the number of mutants affordable to do experimentally (e.g., 20 in the discussion of
set L).
Based on this approach, qualitative activity of 15 out of 22 mutants is correctly
predicted. It is noted that the correlation is best for mutants with largest activity difference
compared to wild type (both positive or negative). For example the method identifies
four of the six most active mutants with≥3-fold wild type activity. Similarly, the method
identifies seven out of the eight least active mutants with≤0.5-fold wild type activity. For
mutants with only small differences in activity compared to wild type, the predictions are
less accurate.
Set L: Large scale screening study
Set L is screened to identify new mutants for which increased activity is predicted. The 20
mutants with the lowest barriers are suggested as candidates for further experimental study
in Table 5. The distributions of reaction barriers, resolved by mutations at positions 104
and 189, are shown in Figs. 5A and 5B.
In set L, three new mutants are identified with barriers lower than the predicted wild
type barrier. Out of the 20 mutants suggested in Table 5, three are double mutants, seven
are three-fold and ten are four-fold mutants. No single mutants were found for which
increased activity compared to wild type is predicted. All mutants except one contain the
G39A mutation, five contain the T103G mutation, six contain a mutation of W104, 13
contain a mutation of A141, 16 contain a mutation of I189 and eight contain the L278A
mutation. From this observation it is likely that mutations of G39, A141 and I189 will likely
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Figure 5 Barrier scatter plots of set L. In both panels, the labels indicate mutants containing the labeled
and possibly additional mutations up to the indicated order. “OTHER” indicates a mutant not containing
any of the labeled mutations or of higher than 4 order. (A) Mutations of W104. (B) Mutations of I189.
Table 5 Selection of mutants from set L with lowest barriers.
Mutation Barrier [kcal/mol]
G39A-T103G-I189Y 5.7
G39A-I189Y 6.2
G39A-A141Q-I189G-L278A 6.3
G39A-A141N-L278A 7.6
G39A-A141N 7.7
G39A-A141N-I189H-L278A 8.3
G39A-W104F-A141Q-I189A 8.3
G39A-A141Q-I189N 9.1
G39A-A141N-I189N 9.3
G39A-T103G-W104Y-A141N 9.8
G39A-W104Y-I189Y 9.8
G39A-A141N-I189N-L278A 10.1
G39A-W104F-A141N 10.1
G39A-I189H-L278A 10.2
G39A-A141N-I189A-L278A 10.2
W104Y-I189H 10.4
G39A-T103G-W104F-I189Y 10.4
G39A-A141Q-I189A-L278A 10.4
G39A-T103G-A141Q-I189H 10.4
G39A-T103G-I189A-L278A 10.5
contribute to an increased activity of the mutant and should thus be included in future
experimental activity assays.
Set L is further analysed in terms of the effect of the mutations at positions 104 and 189.
For the mutations of W104, we note that single mutations which give rise to relatively high
barriers (W104Q, W104Y, Fig. 5A) can have significantly lower barriers in combination
with other mutations. For example, out of the sixty mutants with lowest barriers (Fig. S3),
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33 contain a mutation of W104 out of which 17 are suggested to be W104F, while 14 are
suggested to be W104Y (two contain W104Q).
The mutation of I189 is analysed in a similar way. In set L, five different mutations of
this residue are screened (Table 3). The single mutant with the lowest barrier is I189Y and
the two mutants with the lowest predicted barrier contain this mutation as well (Table 5).
Similarly to above, higher order mutants containing I189A, I189G, I189H or I189N are
predicted to have considerably lower barriers than the corresponding single mutants, Fig.
5B. Particularly, out of the mutants listed in Table 5, three contain the I189A, one contains
I189G mutation, four contain the I189H mutation and three contain the I189N mutation.
As a special case we highlight that the single mutant I189G has one of the highest
calculated barriers (18.9 kcal/mol, Table 1), however, the four-fold mutant G39A-A141Q-
I189G-L278A has one of the lowest barriers (6.3 kcal/mol, Table 5). Interestingly, the
mutant G39A-A141Q-L278A has an intermediate barrier (10.9 kcal/mol). It would appear
that I189G as a single mutant is counterproductive (high computed barrier) but lowers the
barrier of G39A-A141Q-L278A. This observation is further supported by the observation
that the I189G mutation is in spatial proximity to A141Q. While it is difficult to quantify
the interaction, it is likely that in the mutant, the rather large side chain of A141Q is better
accommodated in the active site and can better interact with the substrate.
Observations such as these should be kept in mind when selecting the single mutants for
consideration when preparing higher order mutants.
CONCLUSIONS
Our previously presented method for high throughput computational screening of mutant
activity (Hediger et al., 2012) is benchmarked against experimentally measured amidase
activity for 22 mutants of Candida antarctica lipase B (CalB).
Experimentally, amidase activity is successfully introduced in 12 mutants, the highest
activity is determined to be 11.2-fold over the wild type activity.
Using an appropriate cutoff criterion for the computed barriers, the qualitative activity
of 15 out of 22 mutants is correctly predicted. It is noted that the correlation is best
for mutants with largest activity difference compared to wild type (both positive and
negative). For example the method identifies four of the six most active mutants with
≥3-fold wild type activity. Similarly, the method identifies seven out of the eight least active
mutants with≤0.5-fold wild type activity.
Thus validated, the computational method is used to screen all sterically possible (386)
double-, triple- and quadrupole-mutants constructed from the most active single mutants.
Based on the benchmark test at least 20 new promising mutants are identified.
These mutants have so far not been tested experimentally and are thus offered as
scientifically testable predictions. Interestingly, we observe that single mutants that are
predicted to have low activity appear to have high activity in combination with other
mutants. This is illustrated in specific analysis of effects of mutations of two different
positions (104 and 189).
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